跳至主要内容
临床试验/IRCT20200825048515N29
IRCT20200825048515N29招募中未知

Evaluation of the effect of Livergol (silymarin extract) in reducing peripheral neuropathies induced by cisplatin in patients undergoing chemotherapy

Esfahan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age over 18 years
  • Newly diagnosed cancer and undergoing chemotherapy with cisplatin
  • Having symptoms of peripheral neuropathy after starting chemotherapy
  • Consent to participate in this study

排除标准

  • Having multiple myeloma
  • Having previous neurological disorders
  • Having diseases that give rise to peripheral neuropathy (such as diabetes)

研究者

相似试验